Sticking With This Ondas Price Target After Sales Guidance Update
The small-cap firm crushed expectations, though with some mixed results.
On a High Note: I’m Buying More Alto, Taking Aim at Another Stock
Here’s why I’m buying more Alto Ingredients, and looking to gun it for this stock.
Sticking With This Alto Ingredients Price Target Amid Turnaround
The small-cap firm enjoyed some strong results.
Buying More Rocket Lab After $397 Million Update
The aerospace firm has been awarded a significant contract by the U.S. Space Force.
The $10K Portfolio: Gunnin’ for Some More Smith & Wesson
As gun ownership appears to be on the rise, I’m adding to this weapons maker. Also, I’m eyeing an exit for this stock.
Sticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward
The small-cap healthcare firm offered some encouraging earnings results.
Adding to a Couple of Troubled Positions as July Comes to a Close
Here’s our trading plan for Friday and the upcoming earnings calendar for portfolio names.
Cutting SoFi as ‘Misleading’ Report Continues to Weight on Share Price
The financial services firm has taken a turn for the worse.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.
5 Stocks We Want to Buy on Weakness Ahead of Earnings
Here’s our shopping list for Friday as well as the latest portfolio news.